Chemotherapy and COVID-19 Outcomes in Patients With Cancer.

Justin Jee Michael B Foote Melissa A Lumish Aaron James StonestromBeatriz WillsVarun NarendraViswatej AvutuYonina R Murciano-GoroffJason E Chan Andriy Derkach John Philip Rimma BelenkayaMarina KerpelevMolly MaloyAdam WatsonChris FongYelena JanjigianLuis A Diaz Kelly L Bolton Melissa S Pessin

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)

Recent cytotoxic chemotherapy treatment was not associated with adverse COVID-19 outcomes. Patients with active hematologic or lung malignancies, peri-COVID-19 lymphopenia, or baseline neutropenia had worse COVID-19 outcomes. Interactions among antineoplastic therapy, cancer type, and COVID-19 are complex and warrant further investigation.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
stem cells
emergency department
locally advanced
radiation therapy
metabolic syndrome
rectal cancer
cell therapy
smoking cessation